SAN

79.74

-4.42%↓

MRK1

117.15

-0.51%↓

SHL.DE

44.05

+0.11%↑

ARGX

697.4

-7.29%↓

FRE

48.61

+1.78%↑

SAN

79.74

-4.42%↓

MRK1

117.15

-0.51%↓

SHL.DE

44.05

+0.11%↑

ARGX

697.4

-7.29%↓

FRE

48.61

+1.78%↑

SAN

79.74

-4.42%↓

MRK1

117.15

-0.51%↓

SHL.DE

44.05

+0.11%↑

ARGX

697.4

-7.29%↓

FRE

48.61

+1.78%↑

SAN

79.74

-4.42%↓

MRK1

117.15

-0.51%↓

SHL.DE

44.05

+0.11%↑

ARGX

697.4

-7.29%↓

FRE

48.61

+1.78%↑

SAN

79.74

-4.42%↓

MRK1

117.15

-0.51%↓

SHL.DE

44.05

+0.11%↑

ARGX

697.4

-7.29%↓

FRE

48.61

+1.78%↑

Home・Aktien・Vetoquinol SA

Vetoquinol SA

Open

BrancheGesundheitswesen

77.1 0.13

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

75.6

Max

77.2

Schlüsselkennzahlen
By Trading Economics
Einkommen	-9.8M 25M
Verkäufe	-17M 258M
KGV Branchendurchschnitt	15.137 77.671
Dividendenrendite	1.19
Gewinnspanne	9.734
Angestellte	2,497
EBITDA	-12M 48M

Dividenden
By Dow Jones
Dividendenrendite Branchendurchschnitt	1.19% 2.35%

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	3.7M 913M
Vorheriger Eröffnungskurs	76.97
Vorheriger Schlusskurs	77.1

Nachrichtenstimmung

By Acuity

50%

158 / 374 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Bearish Evidence

72.6 / 75.1 Unterstützung & Widerstand

Vetoquinol SA Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

14. Dez. 2025, 22:53 UTC

Akquisitionen, Fusionen, Übernahmen

Fortescue to Take Full Control of US$101 Million Copper Miner Alta

13. Dez. 2025, 00:04 UTC

Akquisitionen, Fusionen, Übernahmen

Intel in Talks to Acquire SambaNova in Deal Valued at $1.6 Billion, Bloomberg Reports, Citing Sources

14. Dez. 2025, 23:46 UTC

Market Talk

Gold Edges Higher Amid Some Tailwinds -- Market Talk

14. Dez. 2025, 23:36 UTC

Market Talk

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

14. Dez. 2025, 22:38 UTC

Akquisitionen, Fusionen, Übernahmen

Fortescue to Take Full Control of US$101M Copper Miner Alta

14. Dez. 2025, 22:02 UTC

Akquisitionen, Fusionen, Übernahmen

Fortescue: Transaction Is Consistent With Critical Minerals Strategy

14. Dez. 2025, 22:01 UTC

Akquisitionen, Fusionen, Übernahmen

Fortescue: Alta Owns the Canariaco Project in Northern Peru

14. Dez. 2025, 22:01 UTC

Akquisitionen, Fusionen, Übernahmen

Fortescue: Alta Directors Unanimously Recommend Proposal, Will Vote in Favor

14. Dez. 2025, 22:00 UTC

Akquisitionen, Fusionen, Übernahmen

Fortescue: Agreement Implies Total Equity Value of C$139 Million

14. Dez. 2025, 22:00 UTC

Akquisitionen, Fusionen, Übernahmen

Fortescue to Pay C$1.40/Share for Securities It Does Not Already Own

14. Dez. 2025, 21:59 UTC

Akquisitionen, Fusionen, Übernahmen

Fortescue to Acquire Remaining 64% of Alta Copper

14. Dez. 2025, 17:00 UTC

Ergebnisse

Tonka Trucks Gambled on Keeping Production in China and Survived -- Barely -- WSJ

14. Dez. 2025, 08:30 UTC

Akquisitionen, Fusionen, Übernahmen

Kymera Had a Big Week. This Secretive Hedge Fund Bought $172 Million of Its Stock. -- Barrons.com

13. Dez. 2025, 16:48 UTC

Akquisitionen, Fusionen, Übernahmen

How the War to Win Warner Bros. Discovery Will Be Won -- Barrons.com

13. Dez. 2025, 08:00 UTC

Akquisitionen, Fusionen, Übernahmen

How the War to Win Warner Bros. Discovery Will Be Won -- Barrons.com

13. Dez. 2025, 07:00 UTC

Akquisitionen, Fusionen, Übernahmen

A Chubb/AIG Deal Could Be Good for Shareholders and a Coup for Greenberg Family -- Barrons.com

13. Dez. 2025, 00:24 UTC

Akquisitionen, Fusionen, Übernahmen

Want a Piece Of SpaceX? -- Barrons.com

12. Dez. 2025, 23:49 UTC

Akquisitionen, Fusionen, Übernahmen

Intel in Talks to Acquire SambaNova in Deal Valued at $1.6B, Bloomberg Reports, Citing Sources

12. Dez. 2025, 22:52 UTC

Market Talk

Nike Expected to Show Further Momentum in 2Q Results -- Market Talk

12. Dez. 2025, 22:32 UTC

Ergebnisse

These Stocks Moved the Most Today: Broadcom, Oracle, Fermi, Tilray, Lululemon, Costco, Netskope, and More -- Barrons.com

12. Dez. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

12. Dez. 2025, 20:45 UTC

Ergebnisse

The Best Dividend ETF for Right Now -- and 2026 -- Barrons.com

12. Dez. 2025, 20:41 UTC

Market Talk

Oil Ends Week Lower As Market Frets About Oversupply -- Market Talk

12. Dez. 2025, 20:20 UTC

Market Talk

U.S. Natural Gas Futures Post Hefty Weekly Loss -- Market Talk

12. Dez. 2025, 19:23 UTC

Ergebnisse

Charles Schwab Is Opening New Accounts and Hauling in New Assets Amid Buoyant Stock Market -- Barrons.com

12. Dez. 2025, 18:35 UTC

Akquisitionen, Fusionen, Übernahmen

PNC Financial Expects to Close FirstBank Deal On or About Jan. 5, Subject to Satisfaction of Customary Closing Conditions

12. Dez. 2025, 18:33 UTC

Akquisitionen, Fusionen, Übernahmen

PNC Receives Regulatory Approvals For Acquisition Of FirstBank >PNC

12. Dez. 2025, 18:31 UTC

Market Talk

U.S. Oil Rig Count Edges Up by 1 to 414 -- Market Talk

12. Dez. 2025, 17:49 UTC

Ergebnisse

Tariffs Mean Costco Has Fewer Product Types This Holiday. But It Has Plenty of Pies. -- WSJ

12. Dez. 2025, 17:34 UTC

Akquisitionen, Fusionen, Übernahmen

Orange: Closing Subject to Customary Regulatory Approvals, Other Closing Conditions

Peer-Vergleich

Kursveränderung

Vetoquinol SA Prognose

Rating-Konsens

By TipRanks

0 ratings

Buy

Halten

Sell

Basierend auf 0 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Vetoquinol SA – Dist abgegeben haben.

Technischer Score

By Trading Central

72.6 / 75.1Unterstützung & Widerstand

Recent bearish events outweigh bullish events.

All events are bearish.

Stimmung

By Acuity

158 / 374 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Vetoquinol SA

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.